CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-30 | ARMISTICE CAPITAL, LLC Director | Purchase | +49,303 | $2.35 | $116K | 801,303 |
| 2020-03-27 | ARMISTICE CAPITAL, LLC Director | Purchase | +36,000 | $2.43 | $87K | 752,000 |
| 2020-03-23 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,374 | $2.52 | $3K | 716,000 |
| 2020-03-20 | ARMISTICE CAPITAL, LLC Director | Purchase | +9,626 | $2.50 | $24K | 714,626 |
| 2020-03-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,567 | $2.60 | $4K | 705,000 |
| 2020-03-18 | ARMISTICE CAPITAL, LLC Director | Purchase | +20,000 | $1.91 | $38K | 695,000 |
| 2020-03-18 | ARMISTICE CAPITAL, LLC Director | Purchase | +8,433 | $1.91 | $16K | 703,433 |
| 2020-03-17 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,951,219 | $2.05 | $4.0M | 28,160,605 |
| 2020-03-17 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 28,160,605 | ||
| 2020-03-16 | ARMISTICE CAPITAL, LLC Director | Other disposition | −3,455,129 | 26,209,386 | ||
| 2020-03-16 | ARMISTICE CAPITAL, LLC Director | Other disposition | −0 | 26,209,386 | ||
| 2020-03-16 | ARMISTICE CAPITAL, LLC Director | Other disposition | −0 | 26,621,828 | ||
| 2020-02-03 | COLA MICHAEL F Chief Executive Officer | Grant or award | +75,746 | 75,746 | ||
| 2020-02-03 | COLA MICHAEL F Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,200,000 | 1,200,000 | ||
| 2020-02-03 | NEIL GARRY ARTHUR Chief Medical Officer | Grant or award | +72,282 | 72,282 | ||
| 2020-02-03 | NEIL GARRY ARTHUR Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2020-02-03 | BARER SOL J Director | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2020-02-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +981,282 | $3.98 | $3.9M | 29,664,515 |
| 2020-02-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 29,664,515 | ||
| 2020-02-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +275,000 | $3.98 | $1.1M | 675,000 |
Page 22 of 25 · 500 trades